about
[ALEMTUZUMAB: BENEFITS AND CHALLENGES OF A NEW THERAPY IN MULTIPLE SCLEROSIS].The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome StudyAn observational study of alemtuzumab following fingolimod for multiple sclerosis.Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosisValidation of the fatigue scale for motor and cognitive functions in a danish multiple sclerosis cohort.Practice effect in Symbol Digit Modalities Test in multiple sclerosis patients treated with natalizumab.Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypesReal-life persistence and tolerability with dimethyl fumarateDimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patientsPatient Attitudes to Routine Cognitive Testing in Multiple Sclerosis
P50
Q35693716-FAC7C87C-0A57-48F6-A98E-0B144077666EQ35804573-039E03AC-EF49-402B-82A5-7F940ED853C5Q37579941-479B6971-853F-4F37-819E-6A744E34ABB4Q41484449-3D20342D-0DF1-48C8-8BA4-59D01CEE847EQ47732721-5BB97BDB-A12A-4709-B2B1-6D0E8BA69DADQ50472053-FCA863E8-E91E-4B5B-B1A9-686B88720AFAQ54962608-48E64C79-8441-455B-89E5-050D0383D41BQ58774884-4607BC4F-69F5-4C5C-B919-ACB77FD9A7AFQ89116127-D0BABA68-16F7-4E81-8A69-4200E9FA6F77Q90701124-B5C76F33-59ED-43E4-ADA9-7100E7940F20Q92059791-FBD50BE4-1322-4714-9CEF-58DFE3DCDAB5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tobias Sejbaek
@en
Tobias Sejbaek
@nl
type
label
Tobias Sejbaek
@en
Tobias Sejbaek
@nl
prefLabel
Tobias Sejbaek
@en
Tobias Sejbaek
@nl
P31
P496
0000-0002-7682-2188